All Government articles – Page 16
-
News
Mathematical biologist is UK government’s new chief scientific adviser
Angela McLean is the first woman appointed to the post
-
Business
Thousands of jobs to go as chemicals giants cut costs
Dow and 3M laying off a total of 4500 employees worldwide
-
Business
Contaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
Careers
Advising on science policy at the House of Commons Library
Xameerah Malik helps MPs to navigate the science that influences policy
-
News
EU floats plan that would ban virtually every PFAS currently on the market
Members states will examine proposal to prohibit production, use, sale and import of PFAS into Europe in 2025
-
News
New UK government science department created in cabinet reshuffle
Science leaders call for new secretary of state Michelle Donelan to make resolving Horizon Europe dispute a top priority
-
News
Resource conflict likely to expand as world heads into ‘low-cooperation era’
Critical metals such as cobalt and vanadium could be fought over in the near future, World Economic Forum report claims
-
News
Chemistry Nobel prize-winner joins board of UK’s newest funding agency
Organocatalysis pioneer David MacMillan takes Aria role
-
Business
Merck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
News
US chemist Feng Tao avoids prison sentence for hiding ties to China
Judge’s ruling that professor did not harm his university or funding agency has crushed the government’s case
-
Business
Fatal explosion and fire at chemical plant in China
Five dead, a further eight missing, and 30 more injured at Panjin Haoye Chemical
-
News
Plan for medical isotope production centre floated by Welsh government
Nuclear facility would supply the whole country and further afield
-
Business
Second Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
Opinion
Scientists should speak up and share their views
Striving for objectivity does not mean researchers cannot take part in policy debates
-
News
NIH’s new data sharing policy is coming, and it’s a ‘big cultural shift’
The world’s largest public funder of biomedical research will impose broader, deeper, more detailed data management rule on 25 January
-
Business
3M pledges to exit PFAS manufacturing
Conglomerate will remove fluorochemicals from portfolio in a bid to stay ahead of rapidly tightening regulations
-
Article
The roadmap to a sustainable future for polymers
The RSC’s polymers in liquid formulations task force is laying out the innovations needed to deliver biodegradability and circularity
-
Business
UK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
Business
Chemicals industry roundup 2022
Russia’s invation of Ukraine mounted further pressure onto already strained supply chains
-
Business
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking